Doug Fairlie received his PhD from Monash University in 1994. Following postdoctoral stints in the US (State University of New York at Buffalo) and in Sydney (Centre for Immunology, St Vincent's Hospital), he moved to the Walter and Eliza Hall Institute where he is currently a Lab Head in the Structural Biology Division. His lab is interested in the molecular mechanisms underlying the Bcl-2 regulated pathways and uses a combination of biochemical, cell biology and structural biology techniques to better understand how cell death is regulated, and to create new tools including unnatural peptides that will help in the development of drugs for the treatment of cancer and helminth infections.